Molecular diagnostics of transmissible spongiform encephalopathies

Trends in Molecular Medicine

Volumn 8, Issue 6, 2002, Pages 273-280

  Ingrosso, Loredana ^a   Vetrugno, Vito ^a   Cardone, Franco ^a   Pocchiari, Maurizio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN; BIOLOGICAL MARKER;

BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; BRAIN SPONGIOSIS; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EUROPE; HUMAN; IMMUNOCHEMISTRY; MOLECULAR BIOLOGY; NEUROPATHOLOGY; PRION DISEASE; REVIEW; SAFETY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; ANIMAL; DIAGNOSTIC PROCEDURE; GENETIC MARKER; GENETICS; METABOLISM; METHODOLOGY; PATHOLOGY;

ANIMALS; BIOLOGICAL MARKERS; GENETIC MARKERS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PRION DISEASES; PRPSC PROTEINS;

EID: 0035988619     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(02)02358-4     Document Type: Review

References (66)

1. Prion diseases of humans and animals: Their causes and molecular basis
2. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries
3. MRI of Creutzfeldt-Jakob disease: Imaging features and recommended MRI protocol
4. Diagnosis of new variant Creutzfeldt-Jakob disease
5. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay
6. Spongiform encephalopathies. The prion's progress
7. Separation and properties of cellular and scrapie prion protein
8. Two-dimensional mapping of three phenotype-associated isoforms of the prion protein in sporadic Creutzfeldt-Jakob disease
9. Prions
10. BSE and prions: Uncertainties about the agent
11. The immunobiology of TSE diseases
12. Evidence for an alternative direct route of access for the scrapie agent to the brain bypassing the spinal cord
13. Early spread of scrapie from the gastrointestinal tract to the central nervous system involves autonomic fibers of the splanchnic and vagus nerves
14. Western blot detection of scrapie-associated fibril protein in tissues outside the central nervous system from preclinical scrapie-infected mice
15. Sc detection in the preclinical diagnosis of scrapie
16. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy
17. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples
18. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy
19. Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease
20. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95
21. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: A case-control study
22. Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues
23. Sequential appearance and accumulation of pathognomonic markers in the central nervous system of hamsters orally infected with scrapie
24. Isolation and structural studies of the intact scrapie agent protein
25. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein
26. Molecular pathology of fatal familial insomnia
27. Binding of disease-associated prion protein to plasminogen
28. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding
29. A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases
30. Prions in skeletal muscle
31. Differences in proteinase K resistance and neuronal deposition of abnormal prion proteins characterize bovine spongiform encephalopathy (BSE) and scrapie strains
32. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD
33. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease
34. Prion protein glycotype analysis in familial and sporadic Creutzfeldt-Jakob disease patients
35. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects
36. Novel differences between two human prion strains revealed by two-dimensional gel electrophoresis
37. Screening slaughtered cattle for BSE
38. Validation of a luminescence immunoassay for the detection of PrP(Sc) in brain homogenate
39. Rapid test for the preclinical postmortem diagnosis of BSE in central nervous system tissue
40. Eight prion strains have PrP(Sc) molecules with different conformations
41. Immunoassay of human plasma cellular prion protein
42. Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases
43. Use of capillary electrophoresis and fluorescent labeled peptides to detect the abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathy
44. Sc by multi-spectral ultraviolet fluorescence
45. Putting prions into focus: Application of single molecule detection to the diagnosis of prion diseases
46. Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets
47. Human spongiform encephalopathy: The National Institutes of Health series of 300 cases of experimentally transmitted disease
48. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease
49. CSF detection of the 14-3-3 protein in unselected patients with dementia
50. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease
51. Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease
52. Detection of pathological molecular alterations in scrapie-infected hamster brain by Fourier transform infrared (FT-IR) spectroscopy
53. A novel erythroid-specific marker of transmissible spongiform encephalopathies
54. High incidence of Creutzfeldt-Jakob disease in rural Calabria, Italy
55. A new point mutation of the prion protein gene in Creutzfeldt-Jakob disease
56. Clinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation
57. Genetic epidemiology of Creutzfeldt-Jakob disease in Europe
58. Variant Creutzfeldt-Jakob disease
59. c and Doppel: Insights from mutational analysis
60. Polymorphisms within the prion-like protein gene (Prnd) and their implications in human prion diseases, Alzheimer's disease and other neurological disorders
61. Examination of the human prion protein-like gene doppel for genetic susceptibility to sporadic and variant Creutzfeldt-Jakob disease
62. Genomic organization, comparative analysis, and genetic polymorphisms of the bovine and ovine prion Doppel genes (PRND)
63. HLA-DQ7 antigen and resistance to variant CJD
64. Drug therapy in human and experimental transmissible spongiform encephalopathy
65. WHO Consultation on Diagnostic Procedures for Transmissible Spongiform Encephalopathies: Need for Reference Reagents and Reference Panels
66. Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein